MoCRA Compliance and Cosmetic Safety Substantiation: Building Defensible Safety Assessments at Scale
What You'll Learn
- What the FDA currently expects for cosmetic safety substantiation under MoCRA
- Why SDSs alone are often insufficient for cosmetic safety substantiation
- How to combine ingredient safety data, exposure assessments, and NAMs evidence into a defensible safety assessment
- Best practices for documenting and maintaining compliance-ready records
- How to streamline safety substantiation across large product portfolios
- Approaches for generating consistent regulatory documentation and safety reports
- How automated compliance screening by online marketplaces is changing cosmetic compliance requirements
- Practical strategies for foreign manufacturers selling cosmetics in the U.S.
Cosmetic companies worldwide continue to face growing pressure to comply with FDA MoCRA requirements for product listing and safety substantiation. Dominant online marketplaces are also increasingly adopting automated compliance detection to identify and remove non-compliant listings. MoCRA readiness is becoming not just a regulatory requirement, but also a necessity for maintaining market access. At the same time, many organizations still manage formulation, ingredient, and safety data across disconnected systems and manual workflows. Foreign manufacturers in the US market face additional challenges in adapting existing regulatory processes to evolving FDA expectations.
This webinar will explore practical approaches for streamlining MoCRA-ready safety substantiation for cosmetic formulations at scale, including integrating ingredient intelligence, NAMs data, exposure assessments, and automated report generation into modern formulation workflows. The session will also discuss how improved data connectivity can support more efficient regulatory documentation, traceability, and long-term compliance readiness.
